Multiple System Atrophy (MSA) is a neurodegenerative disease that disrupts the body’s ability to carry out involuntary actions, including breathing, blinking, and blood circulation. This condition, which is rare and highly debilitating, bears resemblances to Parkinson’s disease. MSA impairs the communication between nerve cells and the voluntary nervous system, thereby impacting movement control. The prevalence of MSA is estimated to be around four cases per 100,000 individuals.
Understanding Multiple System Atrophy
Multiple system atrophy (MSA) is a medical condition that was initially documented in 1969. Often considered a lesser-known relative of Parkinson’s disease, MSA and Parkinson’s disease share several common symptoms. Both conditions involve the accumulation of the same protein in the brain. In individuals with MSA, the region of the brain responsible for controlling muscles and autonomic processes gradually becomes impaired. Consequently, various involuntary bodily functions, including bladder and muscle control, blood pressure, breathing, and voluntary muscle movements, are affected.
Causes
The exact cause of degeneration is not yet known, but there are theories that point towards the accumulation of an abnormal protein called alpha-synuclein in the brain. Alpha-synuclein plays a crucial role in facilitating communication between nerve cells. However, when there is an excessive amount of this abnormal protein, it disrupts the smooth flow of communication between these cells.